2016
DOI: 10.5603/ait.a2016.0058
|View full text |Cite
|
Sign up to set email alerts
|

Porównanie wpływu indukcji znieczulenia ogólnego, opartej na małej dawce opioidu, z wykorzystaniem deksmedetomidyny i indukcji znieczulenia ze standardową dawką opioidu na reakcję wywołaną intubacją tchawicy u osób otyłych

Abstract: Background: Anaesthesiologists are facing the problem of an increasing population of morbidly obese patients. In order to minimize the risk of opioid-induced postoperative respiratory failure, the intraoperative administration of opioids should be reduced or replaced with other drugs. The purpose of this study was to compare haemodynamic response elicited by intubation in morbidly obese patients between two variants of anaesthesia induction: fentanylbased or low-opioid using dexmedetomidine. Methods: Forty-two… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
0
0
Order By: Relevance
“…New research is required to study the withdrawal symptoms of the drug and compare them with opioid addiction to see if its abuse potential is higher. Several clinical trials show that dexmedetomidine decreases the risk of respiratory distress with lower opioid dosage and adequate pain reduction [ 103 , 104 ]. Dexmedetomidine is approved for use in obese bariatric surgery and for sleep apnea patients as there is sufficient clinical evidence that it is an effective treatment for those procedures [ 101 ].…”
Section: Reviewmentioning
confidence: 99%
“…New research is required to study the withdrawal symptoms of the drug and compare them with opioid addiction to see if its abuse potential is higher. Several clinical trials show that dexmedetomidine decreases the risk of respiratory distress with lower opioid dosage and adequate pain reduction [ 103 , 104 ]. Dexmedetomidine is approved for use in obese bariatric surgery and for sleep apnea patients as there is sufficient clinical evidence that it is an effective treatment for those procedures [ 101 ].…”
Section: Reviewmentioning
confidence: 99%